Tarsus Pharmaceuticals Inc. (TARS)
Market Open
11 Jun, 16:45
NASDAQ (NGS) NASDAQ (NGS) Primary $
63. 62
+2.35
+3.8324%
$
2.6B Market Cap
- P/E Ratio
- Div Yield
129,799 Volume
-4.18 Eps
$ 61.27
Previous Close Investors:
Want to track TARS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
Tarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.98. This compares to loss of $1.17 per share a year ago.
Zacks | 1 year ago
